Abstract
The inhaled lung-selective pan-JAK inhibitor nezulcitinib appears generally well tolerated in hospitalised patients with severe #COVID-19, with trends for improved oxygenation and clinical status, shortened hospitalisation, and fewer deaths versus placebo https://bit.ly/35Xs1Rf
All Keywords
【초록키워드】 clinical status, death, Inhaled, Placebo, inhibitor, hospitalisation, Oxygenation, appear, hospitalised patient, 【제목키워드】 severe COVID-19, Inhaled, inhibitor, multiple ascending dose, TD-0903,
【초록키워드】 clinical status, death, Inhaled, Placebo, inhibitor, hospitalisation, Oxygenation, appear, hospitalised patient, 【제목키워드】 severe COVID-19, Inhaled, inhibitor, multiple ascending dose, TD-0903,